PharmaBiotech

Pharma cannot make enough new medicines to meet the needs of patients. (AP Photo/Elise Amendola) ASSOCIATED PRESS Five dedicated early-stage funds could enable a pharma sponsor to test as many as 100 compounds in the clinic for a fraction of what it would cost in-house.  With the emergence of molecular […]